Zimmer Net Income from 2010 to 2025
| ZBH Stock | USD 102.38 0.56 0.55% |
Net Income | First Reported 2000-03-31 | Previous Quarter 249.2 M | Current Value 239.5 M | Quarterly Volatility 195.3 M |
Check Zimmer Biomet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zimmer Biomet's main balance sheet or income statement drivers, such as Depreciation And Amortization of 533.7 M, Interest Expense of 145.3 M or Selling General Administrative of 2.1 B, as well as many indicators such as Price To Sales Ratio of 4.46, Dividend Yield of 0.0153 or PTB Ratio of 1.63. Zimmer financial statements analysis is a perfect complement when working with Zimmer Biomet Valuation or Volatility modules.
Zimmer | Net Income | Build AI portfolio with Zimmer Stock |
Latest Zimmer Biomet's Net Income Growth Pattern
Below is the plot of the Net Income of Zimmer Biomet Holdings over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Zimmer Biomet Holdings financial statement analysis. It represents the amount of money remaining after all of Zimmer Biomet Holdings operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Zimmer Biomet's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zimmer Biomet's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 905.2 M | 10 Years Trend |
|
Net Income |
| Timeline |
Zimmer Net Income Regression Statistics
| Arithmetic Mean | 569,133,032 | |
| Geometric Mean | 458,552,964 | |
| Coefficient Of Variation | 95.62 | |
| Mean Deviation | 421,241,403 | |
| Median | 720,100,000 | |
| Standard Deviation | 544,194,643 | |
| Sample Variance | 296147.8T | |
| Range | 2.2B | |
| R-Value | 0.05 | |
| Mean Square Error | 316493.2T | |
| R-Squared | 0 | |
| Significance | 0.85 | |
| Slope | 5,768,129 | |
| Total Sum of Squares | 4442217.1T |
Zimmer Net Income History
Other Fundumenentals of Zimmer Biomet Holdings
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Zimmer Biomet Net Income component correlations
About Zimmer Biomet Financial Statements
Investors use fundamental indicators, such as Zimmer Biomet's Net Income, to determine how well the company is positioned to perform in the future. Although Zimmer Biomet's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Net Income | 905.2 M | 600.2 M | |
| Net Income Applicable To Common Shares | 266.1 M | 252.8 M | |
| Net Income From Continuing Ops | 905.2 M | 462.9 M | |
| Net Income Per Share | 4.45 | 4.67 | |
| Net Income Per E B T | 0.87 | 0.81 |
Currently Active Assets on Macroaxis
| AMT | American Tower Corp | |
| HLTOY | Hellenic Telecommunications Org | |
| NFLX | Netflix | |
| EPGFX | Europac Gold Fund | |
| FTGFF | Firan Technology Group |
Check out the analysis of Zimmer Biomet Correlation against competitors. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.41) | Dividend Share 0.96 | Earnings Share 4.43 | Revenue Per Share | Quarterly Revenue Growth 0.043 |
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.